Discloseable transaction disposal of a subsidiary
Filed with HKEX · Stock code 205 · · 5 pages · English
Summary by 6ix AI
Bfb Health Limited has announced the disposal of a subsidiary through a share transfer agreement, where it will sell its entire stake in the Disposal Company for a specified consideration. Upon completion of the transaction, the Disposal Company will no longer be a subsidiary, and its financial results will not be consolidated into Bfb Health's financial statements. The board believes that this disposal will enhance the group's cash flow and allow for better resource allocation to other opportunities. This transaction is classified as a disclosable transaction under the listing rules, requiring specific reporting and announcement obligations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from BFB Health
Later from BFB Health
- Interim report 2026
- Notification Letter to Registered Shareholder and Reply Form
- Notification Letter to Non-registered Holders and Request Form
- Supplemental announcement on discloseable transaction on disposal of a subsidiary
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Follow BFB Health into a list and get an email when it puts out news.
Follow BFB Health